Serum Interleukin-27 Level in Different Clinical Stages of Lung Cancer

Authors

  • Akbar Soleimani Babadi Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Arda Kiani Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Esmaeil Mortaz Department of Immunology, Faculty of Medicine, Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Kimia Taghavi Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Adnan Khosravi Tobacco Prevention and Control Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Majid Marjani Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Sharareh Seifi Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Habib Emami Tobacco Prevention and Control Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Atefeh Abedini Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran http://orcid.org/0000-0002-4262-9873

DOI:

https://doi.org/10.3889/oamjms.2019.018

Keywords:

Interleukin 27, Lung Cancer, cytokine, NSCLC, SCLC, Serum

Abstract

BACKGROUND: Advanced lung cancer is indicated with rapid disease development. Interleukin 27 (IL-27) is regarded as a cytokine with anti-tumour activities.

AIM: Since, the impact of type of lung cancer on the level of IL-27 in patient’s serum has not yet been investigated; current study evaluated the clinical stages according to American Joint Committee on Cancer (AJCC) criteria, Tumor-Node-Metastasis (TNM) stage and the lung cancer spread (localized or widespread) and it's correlation with serum IL-27.

MATERIAL AND METHODS: Thirty patients with confirmed histopathological lung cancer and 30 cancer-free healthy individuals as the control group were included in the current study. Patients group were assigned to either small cell lung cancer group (SCLC) or non-small cell lung cancer (NSCLC) according to the clinical features and the results of lung biopsy specimens. Level of IL-27 was quantified with enzyme-linked immunosorbent assay (ELISA) test in serum samples.

RESULTS: A significant increase in serum IL-27 level was noticed in individuals with lung cancer in comparison with the control group. The level of serum IL-27 in the NSCL squamous carcinoma (NSCLC-Sc) type was significantly greater than in the NSCLC adenocarcinoma (NSCLC-Ad) type, and in both groups, this variable was more than the control group. The serum IL-27 content level was greater in stage III versus stage IV.

CONCLUSION: The current research confirmed the existence of the anti-tumour components in patients with NSCLC. IL-27 can be utilised in diagnosis and screening in early stages of lung cancer along with the management of patients. Different levels of IL-27 in different types of lung cancers in the current study can lead to design more comprehensive studies in the future.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90. https://doi.org/10.3322/caac.20107 PMid:21296855 DOI: https://doi.org/10.3322/caac.20107

Khan D, Choudhary A, Dutta A, Khan I. Tuberculosis of the glans penis mimicking as carcinoma. Int J Mycobacterial. 2016; 5(3):341-342. https://doi.org/10.1016/j.ijmyco.2016.04.003 PMid:27847021 DOI: https://doi.org/10.1016/j.ijmyco.2016.04.003

Velayati AA, Bakayev V, Bahadori M, et al. Religious and cultural traits in HIV/AIDS epidemics in sub-Saharan Africa. Arch Iranian Med. 2007; 10(4):486–497. PMid:17903054

McIntyre A, Ganti AK. Lung cancer-A global perspective. J Surg Oncol. 2017; 115(5):550-4. https://doi.org/10.1002/jso.24532 PMid:28418583 DOI: https://doi.org/10.1002/jso.24532

Errarhay S, Hmidani N, Fatmi H, Saadi H, Bouchikhi C, Amarti A, et al. Post-menopausal endometrial tuberculosis mimicking carcinoma: An important differential diagnosis to consider. Int J Mycobacteriol. 2013; 2(2):118-20. https://doi.org/10.1016/j.ijmyco.2013.04.004 PMid:26785900

Wollina U, Hansel G, Langner D, Koch A, Schönlebe J, Tchernev G. Rapid Evolving Unilateral Indurated Oozing Facial Plaques in a Patient with Head-and-Neck Cancer: Peripheral T-Cell Lymphoma Not Otherwise Specified (NOS). Open Access Maced J Med Sci. 2017; 5(4):476-479. https://doi.org/10.3889/oamjms.2017.085 PMid:28785337 PMCid:PMC5535662 DOI: https://doi.org/10.3889/oamjms.2017.085

Rihawi A, Huang G, Al-Hajj A, Bootwala Z. A case of tuberculosis and adenocarcinoma coexisting in the same lung lobe. Int J Mycobacteriol. 2016; 5(1):80-2. https://doi.org/10.1016/j.ijmyco.2015.07.001 PMid:26927994 DOI: https://doi.org/10.1016/j.ijmyco.2015.07.001

Kiani A, Taghavi K, Rokni-Yazdi H, Abedini A. Application of Microwave Ablation for Treating Pulmonary Adenocarcinoma: A Case Report. Tanaffos. 2017; 16(4):304-308. PMid:29849688 PMCid:PMC5971762

Idrees F, Kamal S, Irfan M, Ahmed R. Endobronchial tuberculosis presented as multiple endobronchial vesicular lesions. Int J Mycobacteriol. 2015; 4(2):154-7. https://doi.org/10.1016/j.ijmyco.2015.02.005 PMid:26972885 DOI: https://doi.org/10.1016/j.ijmyco.2015.02.005

Shafiepour M, Kiani A, Taghavi K, Seifi S, Rezaie MS, Hashemian SMR, et al. A Rare Report of Lung Metastasis of the Common Non-Melanotic Skin Cancer. Tanaffos. 2018; 17(1):62-65. PMid:30116282 PMCid:PMC6087531

Masood KI, Irfan M, Masood Q, Jamil B, Rao S, Rahim M, et al. Increased Mycobacterium tuberculosis antigen-induced gene expression of interferon-gamma, tumor necrosis factor alpha and interleukin-6 in patients with diabetes. Int J Mycobacteriol. 2016; Suppl 1:S246. https://doi.org/10.1016/j.ijmyco.2016.09.001 PMid:28043584 DOI: https://doi.org/10.1016/j.ijmyco.2016.09.001

Errarhay S, Hmidani N, Fatmi H, Saadi H, Bouchikhi C, Amarti A, et al. Post-menopausal endometrial tuberculosis mimicking carcinoma: An important differential diagnosis to consider. Int J Mycobacteriol. 2013; 2(2):118-20. https://doi.org/10.1016/j.ijmyco.2013.04.004 PMid:26785900 DOI: https://doi.org/10.1016/j.ijmyco.2013.04.004

Barrera L, Montes-Servin E, Barrera A, Ramirez-Tirado LA, Salinas-Parra F, Banales-Mendez JL, et al. Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosis. Ann Oncol. 2015; 26(2):428-35. https://doi.org/10.1093/annonc/mdu549 PMid:25467015 DOI: https://doi.org/10.1093/annonc/mdu549

Minkov P, Gulubova M, Chilingirov P, Ananiev J. The Position of Neutrophils-To-Lymphocytes and Lymphocytes-To-Platelets Ratio as Predictive Markers of Progression and Prognosis in Patients with Non-Small Cell Lung Cancer. Open Access Maced J Med Sci. 2018; 6(8):1382-1386. https://doi.org/10.3889/oamjms.2018.210 DOI: https://doi.org/10.3889/oamjms.2018.210

Shi J, Yuan M, Liu S, Duan X, Chen J. Correlation of IL-27 genetic polymorphisms with the risk and survival of cervical cancer in a Chinese Han population. Tumour Biol. 2016; 37(5):6875-9. https://doi.org/10.1007/s13277-015-4512-x PMid:26662568 DOI: https://doi.org/10.1007/s13277-015-4512-x

Hunter CA, Kastelein R. Interleukin-27: balancing protective and pathological immunity. Immunity. 2012; 37(6):960-9. https://doi.org/10.1016/j.immuni.2012.11.003 PMid:23244718 PMCid:PMC3531794 DOI: https://doi.org/10.1016/j.immuni.2012.11.003

Naumnik W, Naumnik B, Niewiarowska K, Ossolinska M, Chyczewska E. Novel cytokines: IL-27, IL-29, IL-31 and IL-33. Can they be useful in clinical practice at the time diagnosis of lung cancer? Exp Oncol. 2012; 34(4):348-53. PMid:23302994

Duan M, Ning Z, Fu Z, Zhang J, Liu G, Wei Q, et al. Decreased IL-27 Negatively Correlated with Th17 Cells in Non-Small-Cell Lung Cancer Patients. Mediators Inflamm. 2015; 2015:802939. https://doi.org/10.1155/2015/802939 PMid:25969628 PMCid:PMC4417605 DOI: https://doi.org/10.1155/2015/802939

Karlicic V, Vukovic J, Stanojevic I, Sotirovic J, Peric A, Jovic M, et al. IL-27 Concentration in Systemic Circulation and Tumor Micro-Circulation Samples of Sclc and Nsclc Patients; Association with Tumor Size, Histological Type and Presence of Metastases. Austin J Clin Immunol. 2016; 3(1):1030.

Friedman A, Liao KL. The role of the cytokines IL-27 and IL-35 in cancer. Math Biosci Eng. 2015; 12(6):1203-17. https://doi.org/10.3934/mbe.2015.12.1203 PMid:26775857 DOI: https://doi.org/10.3934/mbe.2015.12.1203

Cancer Genome Atlas Research N. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012; 489(7417):519-25. https://doi.org/10.1038/nature11404 PMid:22960745 PMCid:PMC3466113 DOI: https://doi.org/10.1038/nature11404

Singletary SE, Allred C, Ashley P, et al. Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am. 2003; 83(4):803-19. https://doi.org/10.1016/S0039-6109(03)00034-3 DOI: https://doi.org/10.1016/S0039-6109(03)00034-3

Zhang M, Tan X, Huang J, Ke Z, Ge Y, Xiong H, et al. Association of 3 Common Polymorphisms of IL-27 Gene with Susceptibility to Cancer in Chinese: Evidence From an Updated Meta-Analysis of 27 Studies. Med Sci Monit. 2015; 21(25):05-13. https://doi.org/10.12659/MSM.895032 DOI: https://doi.org/10.12659/MSM.895032

Published

2019-01-05

How to Cite

1.
Soleimani Babadi A, Kiani A, Mortaz E, Taghavi K, Khosravi A, Marjani M, Seifi S, Emami H, Abedini A. Serum Interleukin-27 Level in Different Clinical Stages of Lung Cancer. Open Access Maced J Med Sci [Internet]. 2019 Jan. 5 [cited 2024 Apr. 18];7(1):45-9. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2019.018

Issue

Section

B - Clinical Sciences